Different T-cell Receptor (TCR) Zeta Chain Expression in Cervical Cancer and its Precursor Lesions

Objective: Material and Methods: Results: Conclusions: Einleitung: Methode: Ergebnisse: Schlussfolgerung:

[1]  M. Lotze,et al.  Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Novick,et al.  Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Rudolf,et al.  Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  H. Kalthoff,et al.  Systemic and local immunosuppression in pancreatic cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  G. Parham,et al.  Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  H. Pilch,et al.  Human Papillomavirus Type 33 E7 Peptides Presented by HLA-DR*0402 to Tumor-Infiltrating T Cells in Cervical Cancer , 2000, Journal of Virology.

[7]  B. Seliger,et al.  CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7. , 1999, Journal of immunology.

[8]  Dalgleish,et al.  A lack of evidence for down‐modulation of CD3ζ expression in colorectal carcinoma and pregnancy using multiple detection methods , 1999, Clinical and experimental immunology.

[9]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[10]  P. Lograsso,et al.  Mechanism of activation for Zap-70 catalytic activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Wilander,et al.  Nonradioisotopic Detection and Typing of Human Papillomaviruses by Use of Polymerase Chain Reaction and Single‐strand Conformation Polymorphism , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[12]  E. Wilander,et al.  Two consensus primer systems and nested polymerase chain reaction for human papillomavirus detection in cervical biopsies: A study of sensitivity. , 1996, Human pathology.

[13]  Theresa,et al.  Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  E. Wilander,et al.  Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques , 1996, Virchows Archiv.

[15]  C. Melief,et al.  Cellular immunity against human papillomavirus associated cervical cancer , 1996 .

[16]  D. Longo,et al.  Alterations in T cell receptor and signal transduction molecules in melanoma patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[18]  Expression of CD 56 by Human Papillomavirus E 7-specific CD 8 + Cytotoxic T Lymphocytes Correlates with Increased Intracellular Perforin Expression and Enhanced Cytotoxicity against HLA-A 2-matched Cervical Tumor Cells 1 , 2007 .

[19]  M. Lan,et al.  L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  K. Kayser,et al.  Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection. , 2001, Immunology.

[21]  C. Slaughter,et al.  The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations. , 2000, Nature immunology.

[22]  T. Whiteside,et al.  Caspase-mediated degradation of T-cell receptor zeta-chain. , 1999, Cancer research.

[23]  B. Seliger,et al.  CD 4 1 Tumor-Infiltrating Lymphocytes in Cervical Cancer Recognize HLA-DR-Restricted Peptides Provided by Human Papillomavirus-E 7 , 1999 .

[24]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.